Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: An Italian multicentric survey

Leukemia and Lymphoma

Volumn 55, Issue 4, 2014, Pages 841-847

  D'Arena, Giovanni ^a   Laurenti, Luca ^b   Coscia, Marta ^c   Cortelezzi, Agostino ^d   Chiarenza, Annalisa ^e   Pozzato, Gabriele ^f   Vigliotti, Maria Luigia ^g   Nunziata, Giuseppe ^h   Fragasso, Alberto ⁱ   Villa, Maria Rosaria ^j   Grossi, Alberto ^k   Selleri, Carmine ^l   Deaglio, Silvia ^c   La Sala, Antonio ^m   Del Poeta, Giovanni ⁿ   Simeon, Vittorio ^a   Aliberti, Luig ^o   De Martino, Laura ^o   Giudice, Aldo ^p   Musto, Pellegrino ^a   De Feo, Vincenzo ^o   more..

^a REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f UNIVERSITY OF TRIESTE   (Italy)

^g S Anna S Sebastiano Hospital   (Italy)

^h CARDARELLI HOSPITAL   (Italy)

ⁱ Potenza/Madonna delle Grazie Hosp   (Italy)

^j San Gennaro Hospital   (Italy)

^k Orthopaedics Unit IFCA Institute   (Italy)

^l UNIVERSITY HOSPITAL SAN GIOVANNI DI DIO E RUGGI D ARAGONA   (Italy)

^m CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

ⁿ UNIVERSITY OF ROME TOR VERGATA   (Italy)

^o UNIVERSITY OF SALERNO   (Italy)

^p NATIONAL CANCER INSTITUTE   (Italy)

more..

Author keywords

Erythrocytes; Leukemic progenitor cells; Lymphocytes

Indexed keywords

CARICA PAPAYA EXTRACT; CHAMOMILE; COLCHIUM AUTUMNALE EXTRACT; EMODIN; ESCUZUL; GARLIC EXTRACT; GREEN TEA EXTRACT; HARPAGOPHYTUM PROCUMBENS EXTRACT; LYCOPENE; MALVA EXTRACT; MELATONIN; NATURAL PRODUCT; ORANGE EXTRACT; OREGANO EXTRACT; PARIS QUADRIFONIA EXTRACT; PLANT EXTRACT; RESVERATROL; ROSA CANINA EXTRACT; ROSMARINUS OFFICINALIS EXTRACT; SABAL EXTRACT; TILIA EXTRACT; UNCLASSIFIED DRUG; VALERIANA EXTRACT; VERBENA EXTRACT; VITAMIN;

ADULT; AGE; AGED; ALOE; ALTERNATIVE MEDICINE; ARTICLE; CANCER PATIENT; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; GENDER; HUMAN; INTERNET; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PATIENT EDUCATION; PRIORITY JOURNAL; TEA; VITAMIN SUPPLEMENTATION; CANCER STAGING; CLINICAL TRIAL; GEOGRAPHY; HEALTH CARE SURVEY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MIDDLE AGED; MULTICENTER STUDY; QUESTIONNAIRE; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COMPLEMENTARY THERAPIES; FEMALE; GEOGRAPHY; HEALTH CARE SURVEYS; HUMANS; ITALY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; QUESTIONNAIRES; RISK FACTORS;

EID: 84904277201     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.803223     Document Type: Article

References (19)

1. National Center for Complementary and Alternative Medicine (NCCAM). What is CAM? Available from: http://nccam.nih.gov/health/whatiscam/
2. Ernst E, Cassileth BR. The prevalence ofcomplementary/alternative medicine in cancer: a systematic review. Cancer 1998;83:777-782. (Pubitemid 28387704)
3. Patterson RE, Neuhouser ML, Hedderson MM, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med 2002;8:477-485. (Pubitemid 34994542)
4. Richardson MA, Sanders T, Palmer JL, et al. Complementary /alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505-2514. (Pubitemid 30432515)
5. Molassiotis A, Fernandez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients; a European survey. Ann Oncol 2005;16:655-663. (Pubitemid 40613334)
6. Molassiotis A, Margulies A, Fernandez-Ortega P, et al. Complementary and alternative medicine use in patients with hematological malignancies in Europe. Complement Ther Clin Pract 2005;11:105-110. (Pubitemid 40631275)
7. Gupta M, Shafiq N, Kumari S, et al. Patterns and perceptions of complementary and alternative medicine (CAM) among leukaemia patients visiting hematology clinic of a north Indian tertiary care hospital.Pharmacoepidemiol Drug Saf 2002; 11: 671-676. (Pubitemid 35469362)
8. Ben-Arye E, Attias S, Tadmor T, et al. Herbs in hemato-oncological care: an evidence-based review of data on efficacy, safety, and drug interactions. Leuk Lymphoma 2010;51:1414-1423.
9. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804-815.
10. Gribben JG. Howl treat CLL up front. Blood 2010;115:187-197.
11. Hensel M, Zoz M, Ho AD. Complementary and alternative medicine in patients with chronic lymphocytic leukemia. Support Care Cancer 2009;17:47-52.
12. Menniti-Ippolito F, Gargiulo L, Bologna E, et al. Use of unconventional medicine in Italy: a nation-wide survey. Eur J Clin Pharmacol 2002; 58: 61-64. (Pubitemid 34327995)
13. Frass M, Strassl RP, Friehs H, et al. Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner J 2012; 12: 45-56.
14. Johannessen H, von Bornemann HJ, Pasquarelli E, et al. Prevalence in the use of complementary medicine among cancer patients in Tuscany, Italy. Tumori 2008;94:406-410.
15. Saini A, Berruti A, Capogna S, et al. Prevalence of complementary/ alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features. Qual Life J 2011;20: 683-690.
16. Shanafelt TD, Call TG, Zent CS, et al. Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Raistage 0 to II chronic lymphocytic leukemia. Cancer 2013; 119: 363-370.
17. Rosenthal DS, Dean-Clower E.Integrative medicine in hematology/oncology: benefits, ethical considerations, and controversies. Hematology 2005; 1: 491-497.
18. Golden EB, LamPY, Kardosh A, et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009; 113: 5927-5937.
19. Shah JJ, Kuhn DJ, Orlowski RZ. Bortezomib and EGCG: no grean tea for you? Blood 2009; 113; 5695-5696.